Evaluation of Balance Using the Biodex Balance System Among Different Subcategories of Low Back Pain

NCT07242976 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-11-21

No results posted yet for this study

Summary

this study aims to evaluate balance using the biodex balance system among patients with spondylosis, spondylolisthesis, and lumber disc prolapse.

Conditions

  • Low Back Pain
  • Spondylolisthesis
  • Spondylosis Lumbar
  • Balance Assessment

Interventions

DIAGNOSTIC_TEST

Assessment of balance will be measured by The Biodex Balance System (BBS) which computes Postural Stability key indices: the medial-lateral stability index (MLSI), anterior-posterior stability index

Low back pain (LBP) is a leading cause of disability worldwide and is often associated with postural and balance impairments. However, limited evidence exists on how these deficits differ among specific types of LBP such as lumbar spondylosis, spondylolisthesis, and disc prolapse. Understanding these variations is crucial for accurate assessment and targeted rehabilitation. Evaluating balance using the Biodex Balance System can help identify the extent of impairment and guide physiotherapists in developing individualized rehabilitation programs that enhance postural control, stability, and functional performance, ultimately improving quality of life and reducing fall risk among LBP patients.

Sponsors & Collaborators

  • Delta University for Science and Technology

    collaborator OTHER
  • Cairo University

    lead OTHER

Principal Investigators

  • Enas F Yousef, Professor of Physical Therapy · Physical Therapy for Musculoskeletal Disorders and Its Surgery, Faculty of Physical Therapy, Cairo University

  • MOAAZ R RIYAD, Lecturer · Lecturer of Department of Physical Therapy for Musculoskeletal Disorders and Its Surgery

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-02-03
Completion
2026-02-03

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07242976 on ClinicalTrials.gov